MORARI, MICHELE
MORARI, MICHELE
Dipartimento di Scienze del Farmaco - DSF
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices
1995 Bianchi, Clementina; Ferraro, Luca Nicola; Tanganelli, Sergio; Morari, Michele; Spalluto, Giampiero; Simonato, Michele; Beani, Lorenzo
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
2020 Vegas-Suarez, S.; Pisano, C. A.; Requejo, C.; Bengoetxea, H.; Lafuente, J. V.; Morari, M.; Miguelez, C.; Ugedo, L.
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
2017 Longo, Francesco; Mercatelli, Daniela; Novello, Salvatore; Arcuri, Ludovico; Brugnoli, Alberto; Vincenzi, Fabrizio; Russo, Isabella; Berti, Giulia; Mabrouk, Omar S; Kennedy, Robert T; Shimshek, Derya R; Varani, Katia; Bubacco, Luigi; Greggio, Elisa; Morari, Michele
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance
1991 Beani, Lorenzo; Bianchi, Clementina; Ferraro, Luca Nicola; Morari, Michele; Simonato, Michele; Spalluto, Giampiero; Tanganelli, Sergio
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels
2011 Bido, Simone; Marti, Matteo; Morari, Michele
An innovative approach to treat levodopa-induced dyskinesia based on targeting striatal intracellular signalling. Ente finanziatore Fondazione S. Paolo
2009 Morari, Michele
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease
2007 Mela, Flora; Marti, Matteo; Dekundy, A; Danysz, W; Morari, Michele; Cenci, Ma
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
2018 Arcuri, L.; Novello, S.; Frassineti, M.; Mercatelli, D.; Pisano, C. A.; Morella, I.; Fasano, S.; Journigan, B. V.; Meyer, M. E.; Polgar, W. E.; Brambilla, R.; Zaveri, N. T.; Morari, M.
Autophagy and LRRK2 in the Aging Brain
2019 Albanese, F.; Novello, S.; Morari, M.
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior
2004 Marti, Matteo; Mela, Flora; Veronesi, Carlo; Guerrini, Remo; Salvadori, Severo; Federici, M; Mercuri, Nb; Rizzi, Anna; Franchi, Gianfranco; Beani, Lorenzo; Bianchi, Clementina; Morari, Michele
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease
2005 Marti, Matteo; Mela, Flora; Fantin, Martina; Zucchini, Silvia; Brown, Jm; Witta, J; DI BENEDETTO, M; Buzas, B; Reinscheid, Rk; Salvadori, Severo; Guerrini, Remo; Romualdi, P; Candeletti, S; Simonato, Michele; Cox, Bm; Morari, Michele
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
2022 Teil, Margaux; Dovero, Sandra; Bourdenx, Mathieu; Arotcarena, Marie-Laure; Camus, Sandrine; Porras, Gregory; Thiolat, Marie-Laure; Trigo-Damas, Ines; Perier, Celine; Estrada, Cristina; Garcia-Carrillo, Nuria; Morari, Michele; Meissner, Wassilios G; Herrero, María Trinidad; Vila, Miquel; Obeso, Jose A; Bezard, Erwan; Dehay, Benjamin
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease
2010 Marti, Matteo; Sarubbo, Silvio; Latini, F.; Cavallo, Michele Alessandro; Eleopra, Roberto; Biguzzi, S.; Lettieri, C.; Conti, C.; Simonato, Michele; Zucchini, Silvia; Quatrale, Rocco; Sensi, Mariachiara; Candeletti, S.; Romualdi, P.; Morari, Michele
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism
2005 Mela, Flora; Marti, Matteo; Bianchi, Clementina; Morari, Michele
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release
2015 Volta, Mattia; Cataldi, Stefano; Beccano Kelly, Dayne; Munsie, Lise; Tatarnikov, Igor; Chou, Patrick; Bergeron, Sabrina; Mitchell, Emma; Lim, Roscoe; Khinda, Jaskaran; Lloret, Alejandro; Bennett, C. Frank; Paradiso, Carmela; Morari, Michele; Farrer, Matthew J.; Milnerwood, Austen J.
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo
2021 Albanese, F.; Mercatelli, D.; Finetti, L.; Lamonaca, G.; Pizzi, S.; Shimshek, D. R.; Bernacchia, G.; Morari, M.
D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain
2015 Cristino, Luigia; Luongo, Livio; Squillace, Marta; Paolone, Giovanna; Mango, Dalila; Piccinin, Sonia; Zianni, Elisa; Imperatore, Roberta; Iannotta, Monica; Longo, Francesco; Errico, Francesco; Vescovi, Angelo Luigi; Morari, Michele; Maione, Sabatino; Gardoni, Fabrizio; Nisticò, Robert; Usiello, Alessandro
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model
2022 Presotto, L; Bettinardi, V; Mercatelli, D; Picchio, M; Morari, M; Moresco, R M; Belloli, Sara
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism
2008 Fantin, Martina; Auberson, Y. P.; Morari, Michele
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia
2015 Bido, Simone; Solari, Nicola; Indrigo, Marzia; D'Antoni, Angela; Brambilla, Riccardo; Morari, Michele; Fasano, Stefania